Study on Bioequivalence of 2 Kinds of Azithromycin Preparations in Healthy Volunteers
Haisheng You, Wang Pei-xian, Xiuqin Wang
Abstract
Haisheng You, Wang Pei-xian, Xiuqin Wang
Abstract
OBJECTIVE:To study the bioequivalence of 2 kinds of azithromycin preparations.METHODS:18 male healthy volunteers were enrolled in randomized controlled crossover design and given a signal oral dose of azithromycin dispersible tablet(test preparation) and azithromycin capsule(reference preparation).Plasma concentration of azithromycin was detected by microbiological method and pharmacokinetic parameters were calculated using 3p97 software.Bioequivalence of 2 kinds of azithromycin preparations were evaluated.RESULTS:Main pharmacokinetic parameters of test preparation vs.reference preparation were as follows:Cmax(0.34±0.06)μg·mL-1 vs.(0.30±0.06)μg·mL-1;tmax(2.40±0.48)h vs.(2.29±0.55)h;AUC0~144(2.80±0.80)μg·h·mL-1 vs.(2.82±1.44)μg·h·mL-1;AUC0~∞(2.95±0.67) μg·h·mL-1 vs.(2.91±1.68) μg·h·mL-1.There was no significant difference between pharmacokinetic parameters of 2 kinds of preparations(P0.05).The relative bioavailability of azithromycin dispersible tablets was(99.29±3.85)%.CONCLUSION:2 kinds of azithromycin preparations are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To study the bioequivalence of 2 kinds of azithromycin preparations.METHODS:18 male healthy volunteers were enrolled in randomized controlled crossover design and given a signal oral dose of azithromycin dispersible tablet(test preparation) and azithromycin capsule(reference preparation).Plasma concentration of azithromycin was detected by microbiological method and pharmacokinetic parameters were calculated using 3p97 software.Bioequivalence of 2 kinds of azithromycin preparations were evaluated.RESULTS:Main pharmacokinetic parameters of test preparation vs.reference preparation were as follows:Cmax(0.34±0.06)μg·mL-1 vs.(0.30±0.06)μg·mL-1;tmax(2.40±0.48)h vs.(2.29±0.55)h;AUC0~144(2.80±0.80)μg·h·mL-1 vs.(2.82±1.44)μg·h·mL-1;AUC0~∞(2.95±0.67) μg·h·mL-1 vs.(2.91±1.68) μg·h·mL-1.There was no significant difference between pharmacokinetic parameters of 2 kinds of preparations(P0.05).The relative bioavailability of azithromycin dispersible tablets was(99.29±3.85)%.CONCLUSION:2 kinds of azithromycin preparations are bioequivalent.
Key concepts: Bioequivalence, Azithromycin, Cmax, Pharmacokinetics, Bioavailability, Crossover study, Capsule, Medicine